Cargando…
Pharmacogenetics of hepatitis C: transition from interferon-based therapies to direct-acting antiviral agents
Hepatitis C virus (HCV) has emerged as a major viral pandemic over the past two decades, infecting 170 million individuals, which equates to approximately 3% of the world’s population. The prevalence of HCV varies according to geographic region, being highest in developing countries such as Egypt. H...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4075960/ https://www.ncbi.nlm.nih.gov/pubmed/25114601 http://dx.doi.org/10.2147/HMER.S41127 |